Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07068191
What this trial is testing

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more
Phenomen Pharma 90
Testing effectiveness (Phase 2)Ended earlyNCT01672879
What this trial is testing

Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH

Who this might be right for
Liver Fibrosis Due to NASH
Gilead Sciences 259
Not applicableLooking for participantsNCT03635541
What this trial is testing

Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Beijing Friendship Hospital 500
Very early researchStudy completedNCT05720702
What this trial is testing

A Feasibility Trial of OCM Supplements for the Treatment of NAFLD

Who this might be right for
NAFLD
Duke University 31
Testing effectiveness (Phase 2)Study completedNCT04505436
What this trial is testing

Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Hanmi Pharmaceutical Company Limited 215
Testing effectiveness (Phase 2)Study completedNCT05824156
What this trial is testing

CM-101 in NASH Patients - The SPLASH Study

Who this might be right for
Nonalcoholic Steatohepatitis
ChemomAb Ltd. 23
Not applicableUnknownNCT05128253
What this trial is testing

Characterization of the Platelet Inflammatory Response in NAFL and NASH

Who this might be right for
NASH - Nonalcoholic SteatohepatitisNAFLD
Stefania Basili 44
Not applicableActive Not RecruitingNCT05165446
What this trial is testing

Novel MRE Technique to Assess a Risk Factor for Liver Cancer

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Natalie Torok 35
Early research (Phase 1)Study completedNCT03674476
What this trial is testing

An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function

Who this might be right for
NAFLDNonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Bristol-Myers Squibb 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04679376
What this trial is testing

Statins for the Treatment of NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Mayo Clinic 70
Testing effectiveness (Phase 2)UnknownNCT04702490
What this trial is testing

Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH

Who this might be right for
NASHNASH - Nonalcoholic SteatohepatitisType 2 Diabetes+5 more
Metacrine, Inc. 120
Not applicableStudy completedNCT04988204
What this trial is testing

Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Icahn School of Medicine at Mount Sinai 20
Not applicableUnknownNCT05733897
What this trial is testing

Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
National Taiwan University Hospital 150
Testing effectiveness (Phase 2)Study completedNCT03639623
What this trial is testing

Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Liver Transplant; ComplicationsNAFLD
Zydus Therapeutics Inc. 20
Early research (Phase 1)Study completedNCT03445208
What this trial is testing

Experimental Medication BMS-986036 Given to Healthy Participants

Who this might be right for
Hepatic CirrhosisLiver FibrosisNonalcoholic Fatty Liver Disease+1 more
Bristol-Myers Squibb 30
Testing effectiveness (Phase 2)Study completedNCT04801849
What this trial is testing

Vitamin E Dosing Study

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 200
Not applicableActive Not RecruitingNCT04132440
What this trial is testing

Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseasePhysician
M.D. Anderson Cancer Center 17
Not applicableActive Not RecruitingNCT05479721
What this trial is testing

LITMUS Imaging Study

Who this might be right for
NAFLDNASHNASH - Nonalcoholic Steatohepatitis+2 more
University of Oxford 450
Large-scale testing (Phase 3)Study completedNCT04197479
What this trial is testing

Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Madrigal Pharmaceuticals, Inc. 1,343
Not applicableNot Yet RecruitingNCT02933554
What this trial is testing

Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis

Who this might be right for
ObesityWeight LossBody Weight+3 more
Keith Pereira, MD: 8
Next Page